How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Buy
53
XEL Quote, Financials, Valuation and Earnings
Last price:
$71.37
Seasonality move
:
2.07%
Day range:
$68.19 - $70.30
52-week range:
$51.97 - $73.38
Dividend yield:
3.21%
P/E ratio:
20.05x
P/S ratio:
2.89x
P/B ratio:
2.03x
Volume:
5.4M
Avg. volume:
3.8M
1-year change:
26.04%
Market cap:
$39.6B
Revenue:
$13.4B
EPS (TTM):
$3.44
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $11.5B | $13.4B | $15.3B | $14.2B | $13.4B | |
| Revenue Growth (YoY) | -0.03% | 16.53% | 13.99% | -7.21% | -5.39% | |
| Cost of Revenues | $6.6B | $8.2B | $9.5B | $8.2B | $7.3B | |
| Gross Profit | $5B | $5.3B | $5.9B | $6B | $6.1B | |
| Gross Profit Margin | 43.07% | 39.15% | 38.28% | 42.09% | 45.74% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $149M | $140M | $98M | $41M | $330M | |
| Operating Expenses | $2.8B | $3.1B | $3.4B | $3.4B | $3.8B | |
| Operating Income | $2.1B | $2.2B | $2.4B | $2.6B | $2.4B | |
| Net Interest Expenses | $798M | $816M | $925M | $1B | $1.2B | |
| EBT. Incl. Unusual Items | $1.5B | $1.5B | $1.6B | $1.6B | $1.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$6M | -$70M | -$135M | -$146M | -$402M | |
| Net Income to Company | $1.5B | $1.6B | $1.7B | $1.8B | $1.9B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.5B | $1.6B | $1.7B | $1.8B | $1.9B | |
| Basic EPS (Cont. Ops) | $2.79 | $2.96 | $3.18 | $3.21 | $3.44 | |
| Diluted EPS (Cont. Ops) | $2.79 | $2.96 | $3.17 | $3.21 | $3.44 | |
| Weighted Average Basic Share | $527M | $539M | $547M | $552M | $563M | |
| Weighted Average Diluted Share | $528M | $540M | $547M | $552M | $563M | |
| EBITDA | $4.3B | $4.6B | $5.1B | $5.2B | $5.6B | |
| EBIT | $2.2B | $2.3B | $2.5B | $2.6B | $2.7B | |
| Revenue (Reported) | $11.5B | $13.4B | $15.3B | $14.2B | $13.4B | |
| Operating Income (Reported) | $2.1B | $2.2B | $2.4B | $2.6B | $2.4B | |
| Operating Income (Adjusted) | $2.2B | $2.3B | $2.5B | $2.6B | $2.7B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $3.4B | $4.1B | $3.4B | $3.1B | |
| Revenue Growth (YoY) | 5.33% | 13.85% | 20.81% | -15.08% | -9.36% | |
| Cost of Revenues | $1.8B | $2.1B | $2.7B | $1.9B | $1.8B | |
| Gross Profit | $1.2B | $1.2B | $1.4B | $1.5B | $1.3B | |
| Gross Profit Margin | 39.26% | 36.01% | 33.75% | 44.39% | 41.28% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $35M | $35M | $38M | -$34M | $117M | |
| Operating Expenses | $731M | $775M | $843M | $880M | $941M | |
| Operating Income | $426M | $433M | $525M | $648M | $347M | |
| Net Interest Expenses | $203M | $206M | $239M | $250M | $297M | |
| EBT. Incl. Unusual Items | $258M | $262M | $324M | $364M | $167M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$30M | -$53M | -$55M | -$45M | -$297M | |
| Net Income to Company | $288M | $315M | $379M | $409M | $464M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $288M | $315M | $379M | $409M | $464M | |
| Basic EPS (Cont. Ops) | $0.54 | $0.58 | $0.69 | $0.74 | $0.81 | |
| Diluted EPS (Cont. Ops) | $0.54 | $0.58 | $0.69 | $0.74 | $0.81 | |
| Weighted Average Basic Share | $530M | $539M | $550M | $555M | $575M | |
| Weighted Average Diluted Share | $531M | $543M | $550M | $555M | $575M | |
| EBITDA | $962M | $1B | $1.2B | $1.3B | $1.2B | |
| EBIT | $433M | $468M | $587M | $614M | $464M | |
| Revenue (Reported) | $2.9B | $3.4B | $4.1B | $3.4B | $3.1B | |
| Operating Income (Reported) | $426M | $433M | $525M | $648M | $347M | |
| Operating Income (Adjusted) | $433M | $468M | $587M | $614M | $464M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $11.5B | $13.4B | $15.3B | $14.2B | $13.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $6.6B | $8.2B | $9.5B | $8.2B | $7.3B | |
| Gross Profit | $5B | $5.3B | $5.9B | $6B | $6.1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $149M | $140M | $98M | $41M | $330M | |
| Operating Expenses | $2.8B | $3.1B | $3.4B | $3.4B | $3.8B | |
| Operating Income | $2.1B | $2.2B | $2.4B | $2.6B | $2.4B | |
| Net Interest Expenses | $798M | $816M | $925M | $1B | $1.2B | |
| EBT. Incl. Unusual Items | $1.5B | $1.5B | $1.6B | $1.6B | $1.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$6M | -$70M | -$135M | -$146M | -$402M | |
| Net Income to Company | $1.5B | $1.6B | $1.7B | $1.8B | $1.9B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.5B | $1.6B | $1.7B | $1.8B | $1.9B | |
| Basic EPS (Cont. Ops) | $2.79 | $2.96 | $3.18 | $3.21 | $3.44 | |
| Diluted EPS (Cont. Ops) | $2.78 | $2.96 | $3.17 | $3.21 | $3.44 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $4.3B | $4.6B | $5.1B | $5.2B | $5.6B | |
| EBIT | $2.2B | $2.3B | $2.5B | $2.6B | $2.7B | |
| Revenue (Reported) | $11.5B | $13.4B | $15.3B | $14.2B | $13.4B | |
| Operating Income (Reported) | $2.1B | $2.2B | $2.4B | $2.6B | $2.4B | |
| Operating Income (Adjusted) | $2.2B | $2.3B | $2.5B | $2.6B | $2.7B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $13.4B | $15.3B | $14.2B | $13.4B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $8.2B | $9.5B | $8.2B | $7.3B | -- | |
| Gross Profit | $5.3B | $5.9B | $6B | $6.1B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $140M | $98M | $41M | $330M | -- | |
| Operating Expenses | $3.1B | $3.4B | $3.4B | $3.8B | -- | |
| Operating Income | $2.2B | $2.4B | $2.6B | $2.4B | -- | |
| Net Interest Expenses | $816M | $925M | $1B | $1.2B | -- | |
| EBT. Incl. Unusual Items | $1.5B | $1.6B | $1.6B | $1.5B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$70M | -$135M | -$146M | -$402M | -- | |
| Net Income to Company | $1.6B | $1.7B | $1.8B | $1.9B | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.6B | $1.7B | $1.8B | $1.9B | -- | |
| Basic EPS (Cont. Ops) | $2.96 | $3.18 | $3.21 | $3.44 | -- | |
| Diluted EPS (Cont. Ops) | $2.96 | $3.17 | $3.21 | $3.44 | -- | |
| Weighted Average Basic Share | $2.2B | $2.2B | $2.2B | $2.3B | -- | |
| Weighted Average Diluted Share | $2.2B | $2.2B | $2.2B | $2.3B | -- | |
| EBITDA | $4.6B | $5.1B | $5.2B | $5.6B | -- | |
| EBIT | $2.3B | $2.5B | $2.6B | $2.7B | -- | |
| Revenue (Reported) | $13.4B | $15.3B | $14.2B | $13.4B | -- | |
| Operating Income (Reported) | $2.2B | $2.4B | $2.6B | $2.4B | -- | |
| Operating Income (Adjusted) | $2.3B | $2.5B | $2.6B | $2.7B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $129M | $166M | $111M | $129M | $179M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $916M | $1B | $1.4B | $1.3B | $1.2B | |
| Inventory | $535M | $631M | $803M | $711M | $666M | |
| Prepaid Expenses | $42M | $44M | $54M | $52M | $72M | |
| Other Current Assets | $890M | $1.4B | $1.4B | $905M | $1.2B | |
| Total Current Assets | $3.3B | $4.2B | $5.1B | $4.1B | $4.3B | |
| Property Plant And Equipment | $44.4B | $46.7B | $49.5B | $52.9B | $58.3B | |
| Long-Term Investments | $3.1B | $3.6B | $3.2B | $3.6B | $3.9B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $379M | $431M | $389M | $678M | $635M | |
| Total Assets | $54B | $57.9B | $61.2B | $64.1B | $70B | |
| Accounts Payable | $1.2B | $1.4B | $1.8B | $1.7B | $1.8B | |
| Accrued Expenses | $203M | $209M | $217M | $251M | $280M | |
| Current Portion Of Long-Term Debt | $1B | $1.6B | $2B | $1.3B | $1.8B | |
| Current Portion Of Capital Lease Obligations | $214M | $205M | $217M | $226M | $227M | |
| Other Current Liabilities | $771M | $799M | $1B | $1.3B | $1.5B | |
| Total Current Liabilities | $4.2B | $5B | $6.1B | $5.7B | $6.5B | |
| Long-Term Debt | $19.6B | $21.8B | $22.8B | $24.9B | $27.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $39.4B | $42.2B | $44.5B | $46.5B | $50.5B | |
| Common Stock | $1.3B | $1.4B | $1.4B | $1.4B | $1.4B | |
| Other Common Equity Adj | -$141M | -$123M | -$93M | -$94M | -$68M | |
| Common Equity | $14.6B | $15.6B | $16.7B | $17.6B | $19.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $14.6B | $15.6B | $16.7B | $17.6B | $19.5B | |
| Total Liabilities and Equity | $54B | $57.9B | $61.2B | $64.1B | $70B | |
| Cash and Short Terms | $129M | $166M | $111M | $129M | $179M | |
| Total Debt | $20.7B | $23.4B | $24.8B | $26.3B | $29.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $129M | $166M | $111M | $129M | $179M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $916M | $1B | $1.4B | $1.3B | $1.2B | |
| Inventory | $535M | $631M | $803M | $711M | $666M | |
| Prepaid Expenses | $42M | $44M | $54M | $52M | $72M | |
| Other Current Assets | $890M | $1.4B | $1.4B | $905M | $1.2B | |
| Total Current Assets | $3.3B | $4.2B | $5.1B | $4.1B | $4.3B | |
| Property Plant And Equipment | $44.4B | $46.7B | $49.5B | $52.9B | $58.3B | |
| Long-Term Investments | $3.1B | $3.6B | $3.2B | $3.6B | $3.9B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $379M | $431M | $389M | $678M | $635M | |
| Total Assets | $54B | $57.9B | $61.2B | $64.1B | $70B | |
| Accounts Payable | $1.2B | $1.4B | $1.8B | $1.7B | $1.8B | |
| Accrued Expenses | $203M | $209M | $217M | $251M | $280M | |
| Current Portion Of Long-Term Debt | $1B | $1.6B | $2B | $1.3B | $1.8B | |
| Current Portion Of Capital Lease Obligations | $214M | $205M | $217M | $226M | $227M | |
| Other Current Liabilities | $771M | $799M | $1B | $1.3B | $1.5B | |
| Total Current Liabilities | $4.2B | $5B | $6.1B | $5.7B | $6.5B | |
| Long-Term Debt | $19.6B | $21.8B | $22.8B | $24.9B | $27.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $39.4B | $42.2B | $44.5B | $46.5B | $50.5B | |
| Common Stock | $1.3B | $1.4B | $1.4B | $1.4B | $1.4B | |
| Other Common Equity Adj | -$141M | -$123M | -$93M | -$94M | -$68M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $14.6B | $15.6B | $16.7B | $17.6B | $19.5B | |
| Total Liabilities and Equity | $54B | $57.9B | $61.2B | $64.1B | $70B | |
| Cash and Short Terms | $129M | $166M | $111M | $129M | $179M | |
| Total Debt | $20.7B | $23.4B | $24.8B | $26.3B | $29.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.5B | $1.6B | $1.7B | $1.8B | $1.9B | |
| Depreciation & Amoritzation | $2.1B | $2.3B | $2.6B | $2.6B | $2.9B | |
| Stock-Based Compensation | $73M | $31M | $20M | $25M | $33M | |
| Change in Accounts Receivable | -$157M | -$313M | -$672M | $225M | $40M | |
| Change in Inventories | -$80M | -$126M | -$203M | -$98M | -$140M | |
| Cash From Operations | $2.8B | $2.2B | $3.9B | $5.3B | $4.6B | |
| Capital Expenditures | $5.4B | $4.2B | $4.6B | $5.9B | $7.4B | |
| Cash Acquisitions | $684M | -- | -- | -- | -- | |
| Cash From Investing | -$4.7B | -$4.3B | -$4.7B | -$5.9B | -$7.4B | |
| Dividends Paid (Ex Special Dividend) | -$856M | -$935M | -$1B | -$1.1B | -$1.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.9B | $2.7B | $2.2B | $2.6B | $3.6B | |
| Long-Term Debt Repaid | -$1B | -$417M | -$793M | -$1.2B | -$746M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$26M | -$10M | -$15M | -$12M | -$6M | |
| Cash From Financing | $1.8B | $2.1B | $666M | $617M | $2.8B | |
| Beginning Cash (CF) | $248M | $129M | $166M | $111M | $129M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$119M | $37M | -$55M | $18M | $50M | |
| Ending Cash (CF) | $129M | $166M | $111M | $129M | $179M | |
| Levered Free Cash Flow | -$2.5B | -$2.1B | -$706M | -$527M | -$2.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $362M | $380M | $418M | $488M | -- | |
| Depreciation & Amoritzation | $547M | $597M | $660M | $684M | -- | |
| Stock-Based Compensation | $9M | $4M | $9M | $6M | -- | |
| Change in Accounts Receivable | $66M | -$45M | $379M | $151M | -- | |
| Change in Inventories | $39M | $107M | $189M | $50M | -- | |
| Cash From Operations | -$136M | $1.1B | $1.5B | $1.1B | -- | |
| Capital Expenditures | $1B | $942M | $1.3B | $1.5B | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1B | -$952M | -$1.3B | -$1.6B | -- | |
| Dividends Paid (Ex Special Dividend) | -$223M | -$240M | -$259M | -$280M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.8B | -- | $266M | $1.5B | -- | |
| Long-Term Debt Repaid | -$400M | -- | -$250M | -$322M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$10M | -$16M | -$13M | -$6M | -- | |
| Cash From Financing | $2.1B | -$264M | -$250M | $878M | -- | |
| Beginning Cash (CF) | $129M | $166M | $111M | $129M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $910M | -$76M | $3M | $372M | -- | |
| Ending Cash (CF) | $1B | $90M | $114M | $501M | -- | |
| Levered Free Cash Flow | -$1.2B | $198M | $272M | -$487M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.5B | $1.6B | $1.7B | $1.8B | $1.9B | |
| Depreciation & Amoritzation | $2.1B | $2.3B | $2.6B | $2.6B | $2.9B | |
| Stock-Based Compensation | $73M | $31M | $20M | $25M | $33M | |
| Change in Accounts Receivable | -$157M | -$313M | -$672M | $225M | $40M | |
| Change in Inventories | -$80M | -$126M | -$203M | -$98M | -$140M | |
| Cash From Operations | $2.8B | $2.2B | $3.9B | $5.3B | $4.6B | |
| Capital Expenditures | $5.4B | $4.2B | $4.6B | $5.9B | $7.4B | |
| Cash Acquisitions | $684M | -- | -- | -- | -- | |
| Cash From Investing | -$4.7B | -$4.3B | -$4.7B | -$5.9B | -$7.4B | |
| Dividends Paid (Ex Special Dividend) | -$856M | -$935M | -$1B | -$1.1B | -$1.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.9B | $2.7B | -- | $2.6B | $3.6B | |
| Long-Term Debt Repaid | -$1B | -$417M | -$793M | -$1.2B | -$746M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$26M | -$10M | -$15M | -$12M | -$6M | |
| Cash From Financing | $1.8B | $2.1B | $666M | $617M | $2.8B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$119M | $37M | -$55M | $18M | $50M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$2.5B | -$2.1B | -$706M | -$527M | -$2.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $362M | $380M | $418M | $488M | -- | |
| Depreciation & Amoritzation | $547M | $597M | $660M | $684M | -- | |
| Stock-Based Compensation | $9M | $4M | $9M | $6M | -- | |
| Change in Accounts Receivable | $66M | -$45M | $379M | $151M | -- | |
| Change in Inventories | $39M | $107M | $189M | $50M | -- | |
| Cash From Operations | -$136M | $1.1B | $1.5B | $1.1B | -- | |
| Capital Expenditures | $1B | $942M | $1.3B | $1.5B | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1B | -$952M | -$1.3B | -$1.6B | -- | |
| Dividends Paid (Ex Special Dividend) | -$223M | -$240M | -$259M | -$280M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.8B | -- | $266M | $1.5B | -- | |
| Long-Term Debt Repaid | -$400M | -- | -$250M | -$322M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$10M | -$16M | -$13M | -$6M | -- | |
| Cash From Financing | $2.1B | -$264M | -$250M | $878M | -- | |
| Beginning Cash (CF) | $129M | $166M | $111M | $129M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $910M | -$76M | $3M | $372M | -- | |
| Ending Cash (CF) | $1B | $90M | $114M | $501M | -- | |
| Levered Free Cash Flow | -$1.2B | $198M | $272M | -$487M | -- | |
Get XEL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
XEL
Sector
P/E ratio
20.05x
14.34x
PEG ratio
2.80x
0.41x
P/B ratio
2.03x
1.43x
Price / LTM sales
2.89x
1.51x
Growth Metrics
XEL
Sector
Revenue growth
-9.36%
0.34%
Earnings growth
9.46%
-0.19%
Revenue (5-year growth)
3.12%
4.68%
Earnings forecast
$0.91
$0.67
Profitability
XEL
Sector
Profitability FY 2024
$6.1B
$1.4B
Return on invested capital
4.15%
3.41%
Return on assets
2.87%
2.49%
Return on equity
10.49%
7.9%
Earnings Date
Last Earnings Date
Feb
6
Next Earnings Date
Apr
24
Estimated Next Earnings Date
May
8
Balance Sheet
XEL
Sector
Total cash
$179M
$385.2M
Short term investments
--
$108.5M
Total assets
$70B
$12.1B
Long term debt
$29.1B
$3.9B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
58
AGX alert for Apr 22
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
